Bosentan Tablet, For Suspension
Product Images NDC 70771-1908

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Bosentan (NDC 70771-1908). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (008fc213 Caa0 4d52 9ee2 E3628c19b90b 01)

Image (008fc213 Caa0 4d52 9ee2 E3628c19b90b 01)
Bosentan Tablets for Oral Suspension 32 mg carton label from Zydus Lifesciences Limited. The package contains 56 tablets (4 x 14 unit-dose) with specific directions for opening the blister pack and storage instructions. The label warns phenylketonurics about phenylalanine content and indicates the product is Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.